Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Narvitas Announces Site Recruitment for its SLAP Study (Study of LapDome's Access Performance)Laparoscopic Surgery Access Platform Could Be the Next Standard of Care. Clinical Perfomance and Complication Reduction to be Studied
By: Narvitas Medical Devices Limited Site recruitment is inclusive of the United States and Ireland. LapDome utilizes a proprietary negative pressure application to the dome shaped device to create a temporary pneumoperitoneum into which inert gas can be delivered. This process creates a rapid and safe access procedure. The SLAP Study will measure safety parameters, as well as, access time, successful inflations with a single “stick”, reduction in bruising, and other risk management associated end points. Glenn Foley, Narvitas Medical Device Ltd.’s Chief Executive Officer stated, “LapDome’s performance to date has been outstanding in reducing Laparoscopic Surgery access time and by the nature of its method, should reduce the potential for access complications and enhance overall patient safety and comfort.” “While LapDome is a Class 1 device and does not require such study, the benefits of demonstrating its clinical and economic benefits under a protocol are acknowledged.” About Narvitas Medical Devices Limited Narvitas Medical Devices Limited is an early stage medical device developer, manufacturer, marketer, and seller. The first device platform from Narvitas is the LapDome Laparoscopic Access Device. LapDome is designed to facilitate a more rapid, safer, and economical initial access to the body to perform laparoscopic or minimally invasive surgery About LapDome® Laparoscopic Access Device LapDome addresses a critical need in the laparoscopic surgery market (one of the largest medical procedure markets) and was developed to advance the standard of care for laparoscopic access. The LapDome device is a proprietary laparoscopic surgery access device. The device is a domed shaped technology that utilizes negative pressure to raise the anterior abdominal wall for rapid and safe access of the abdomen by surgical instruments. Please Note: This release may contain forward-looking statements regarding our prospective performance. Forward-looking statements are based on certain assumptions and describe future plans, strategies, and expectations of our company. Accordingly, actual results may differ. CONTACT: Glenn S Foley Chief Executive Officer +1 732.606.5397 gf@narvitas.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|